Erythropoietin Drugs Market Size, and Trends Forecast 2025-2033
The global erythropoietin drugs market size reached USD 11.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The market growth is primarily driven by the increasing occurrence of chronic diseases, ongoing developments in drug development, including long-acting formulations, and the rising adoption of biosimilars offering cost-effective alternatives, enhancing accessibility, and supporting expansion.
Read More: https://www.imarcgroup.com...
The global erythropoietin drugs market size reached USD 11.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The market growth is primarily driven by the increasing occurrence of chronic diseases, ongoing developments in drug development, including long-acting formulations, and the rising adoption of biosimilars offering cost-effective alternatives, enhancing accessibility, and supporting expansion.
Read More: https://www.imarcgroup.com...
12:15 PM - Mar 05, 2025 (UTC)
